{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:42:08Z","timestamp":1791214928623,"version":"4.1.0"},"reference-count":23,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T00:00:00Z","timestamp":1315872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2011,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recently, a study of patients with rheumatoid arthritis who developed herpes zoster while taking a tumor necrosis factor (TNF)\u2010\u03b1 inhibitor reported a decreased incidence of postherpetic neuralgia. The objective of this study was to investigate whether patients on TNF\u2010\u03b1 inhibitors who developed herpes zoster have a lower incidence of subsequent development of postherpetic neuralgia. A retrospective review of herpes zoster patients on TNF\u2010\u03b1 inhibitors (infliximab, etanercept, or adalimumab) was conducted in 12 dermatology clinics. Medical records of such patients were reviewed thoroughly to confirm herpes zoster and TNF\u2010\u03b1 inhibitors and any subsequent development of postherpetic neuralgia (pain score \u22653 out of 10 after 90 days of shingles onset) was noted. A total of 206 cases were reviewed, of which only 2 cases (&lt;1%) developed postherpetic neuralgia, a considerably lower incidence rate than noted in the literature. Increasing age is a known risk factor in the development of postherpetic neuralgia. However, of the 58 (28.1%) cases \u226570 years of age, only 1 patient (1.7%) developed neuralgia compared to approximately 50% of patients who develop postherpetic neuralgia in this age group as reported in the literature. Treatment with TNF\u2010\u03b1 inhibitors may be associated with a lower incidence of postherpetic neuralgia but further prospective large\u2010scale studies are needed to confirm this data. J. Med. Virol. 83:2051\u20132055, 2011. \u00a9 2011 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jmv.22182","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T19:20:23Z","timestamp":1315941623000},"page":"2051-2055","source":"Crossref","is-referenced-by-count":18,"title":["Possible association of lower rate of postherpetic neuralgia in patients on anti\u2010tumor necrosis factor\u2010\u03b1"],"prefix":"10.1002","volume":"83","author":[{"given":"Saba","family":"Javed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qurat\u2010Ul\u2010Ain","family":"Kamili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen K.","family":"Tyring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,13]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2005.11.002"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000267518.20363.0d"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e31815b32c8"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.02.020"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000140708.62856.72"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(96)03122-3"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.11.1524"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.10.1371"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.016451"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0729"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000123261.00004.29"},{"key":"e_1_2_5_13_1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/01.BRS.0000058944.38900.CE","article-title":"Tumor necrosis factor\u2010alpha monoclonal antibody, infliximab, used to manage severe sciatica","volume":"28","author":"Karppinen J","year":"2003","journal-title":"Spine (PhilaPa 1976)"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/379048"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/19.5.471"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.02.004"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.7.1015"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.09.026"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1529-8027.2000.00012.x"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.146"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.09.021"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21254"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.4065\/82.11.1341"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B0920049"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.22182","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.22182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T05:21:11Z","timestamp":1697606471000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.22182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,13]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["10.1002\/jmv.22182"],"URL":"https:\/\/doi.org\/10.1002\/jmv.22182","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,13]]}}}